Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients with metastatic renal cell carcinoma (mRCC) Meeting Abstract
| Authors: | Amin, A.; Plimack, E. R.; Infante, J. R.; Ernstoff, M. S.; Rini, B.; McDermott, D. F.; Knox, J.; Pal, S. K.; Voss, M. H.; Sharma, P.; Kollmannsberger, C.; Heng, D. Y. C.; Spratlin, J.; Shen, Y.; Kurland, J. F.; Gagnier, P.; Hammers, H. |
| Abstract Title: | Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients with metastatic renal cell carcinoma (mRCC) |
| Meeting Title: | 13th International Kidney Cancer Symposium |
| Journal Title: | BJU International |
| Volume: | 114 |
| Issue: | Suppl. S4 |
| Meeting Dates: | 2014 OCT 24-25 |
| Meeting Location: | Chicago, IL |
| ISSN: | 1464-4096 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2014-10-01 |
| Start Page: | 2 |
| Language: | English |
| ACCESSION: | WOS:000344393900004 |
| PROVIDER: | wos |
| DOI: | 10.1111/bju.12941 |
| Notes: | Meeting Abstract -- Source: Wos |
